Sort   by:  
 Page size 
UnknownDe-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study.
Not available
S-EPMC6594455 | biostudies-literature
UnknownTaxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition.
Not available
S-EPMC4807996 | biostudies-literature
UnknownTargeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity before and after Neoadjuvant Chemotherapy.
Not available
S-EPMC6895966 | biostudies-literature
UnknownEarly stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNA.
Not available
S-EPMC9114063 | biostudies-literature
UnknownBlood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy.
Not available
S-EPMC8010400 | biostudies-literature
UnknownCord red blood cell transfusions for severe retinopathy in preterm neonates in Italy: a multicenter randomized controlled trial.
Not available
S-EPMC12361995 | biostudies-literature
UnknownEarly Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.
Not available
S-EPMC7697290 | biostudies-literature
UnknownNeoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study.
Not available
S-EPMC6685628 | biostudies-literature
UnknownThe TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial.
Not available
S-EPMC9208076 | biostudies-literature
UnknownVaginal delivery in SARS-CoV-2-infected pregnant women in Northern Italy: a retrospective analysis.
Not available
S-EPMC7267664 | biostudies-literature
Sort   by:  
 Page size